Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hippocalcin-like protein 1 (HPCAL1) is a neuron-specific calcium-binding protein, primarily expressed in the retina and brain, and belongs to the neuronal calcium sensor (NCS) protein family with EF-hand domains[2][3][1][5][6]. It closely resembles hippocalcin and is nearly identical in sequence to the rat and mouse homologs. HPCAL1 participates in calcium-dependent signal transduction and phototransduction, potentially influencing rhodopsin phosphorylation in the retina and contributing to neuronal signaling in the central nervous system[2][3][5][6]. Recent research implicates HPCAL1 in multiple disease roles: it acts as a tumor suppressor in hepatocellular carcinoma by stabilizing p21 and inhibiting cell cycle progression[1]; regulates neuronal differentiation (through PHOX2B interaction) with relevance in neuroblastoma pathogenesis[1]; and plays a unique role as an autophagy receptor, selectively mediating CDH2 degradation to promote ferroptotic cell death—particularly relevant in tumor suppression and pancreatitis[4]. Its expression and DNA methylation status are emerging as potential biomarkers in disease, environmental exposure, and forensic tissue identification[1]. HPCAL1 has hundreds of reported protein interactions, including torsinA and CDH2, and may modulate oncogenic signaling via direct activation of DCLK1 kinase[1][4]. It is not yet a direct drug target in clinical therapeutics, but its central functions in calcium homeostasis, neuronal viability, and regulated cell death highlight potential therapeutic relevance[1][4][5][6][7].
Promotes ferroptosis by mediating selective autophagic degradation of cadherin-2 (CDH2); stabilizes p21 to suppress cell cycle progression in cancer[1][4]; regulates calcium-dependent signaling pathways
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hippocalcin-like protein 1 (HPCAL1).